Related Experiment Video
Updated: Feb 8, 2026

04:45
Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome
Published on: June 2, 2022
2.8K
Indomethacin Exacerbates Oleic Acid-Induced Acute Respiratory Distress Syndrome in Adult Rats
Indian Journal of Physiology and Pharmacology
|June 29, 2018
Summary
Prostaglandins are crucial in acute respiratory distress syndrome (ARDS) development. Inhibiting prostaglandin synthesis with indomethacin worsened oleic acid-induced ARDS in rats, indicating a protective role for prostaglandins.
Area of Science:
- Pulmonary Medicine
- Inflammation Research
- Pharmacology
Background:
- Acute respiratory distress syndrome (ARDS) is a severe lung condition characterized by inflammation and respiratory failure.
- The precise role of prostaglandins, known inflammatory mediators, in ARDS pathogenesis remains unclear.
Purpose of the Study:
- To investigate the involvement of prostaglandins in experimentally induced ARDS.
- To determine the effect of prostaglandin synthesis inhibition on ARDS progression.
Main Methods:
- Adult rats were subjected to oleic acid-induced ARDS.
- Prostaglandin synthesis was inhibited using indomethacin prior to oleic acid administration.
- Respiratory frequency, heart rate, mean arterial pressure, arterial blood gas (PaO2/FiO2 ratio), and pulmonary water content were monitored.
Main Results:
- Oleic acid administration led to ARDS, characterized by decreased survival time, altered respiratory and cardiovascular parameters, and increased pulmonary water content.
- Pretreatment with indomethacin significantly exacerbated ARDS, resulting in a drastic reduction in survival time and increased pulmonary edema.
- Indomethacin treatment worsened the physiological derangements observed in oleic acid-induced ARDS.
Conclusions:
- Prostaglandins play a significant role in the pathophysiology of oleic acid-induced ARDS.
- Inhibition of prostaglandin synthesis exacerbates ARDS, suggesting a protective function of prostaglandins in this condition.
Related Concept Videos
Acute Respiratory Failure-I
1.1K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.1K
Acute Respiratory Failure-II
1.1K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.1K
Acute Respiratory Failure-V
510
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
510
Acute Coronary Syndrome I: Introduction
1.0K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.0K
Acute Respiratory Failure-III
926
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
926
Acute Respiratory Failure-IV
575
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
575

